|Articles|August 16, 2018
TrialMaster EDC and Acuity Analytics Selected for Major Clinical Study
Advertisement
A large pharmaceutical company in China will conduct a multisite clinical study using TrialMaster® EDC and Acuity Analytics, from OmniComm Systems, Inc. This company will utilize OmniComm's eClinical solutions in this multicenter, randomized, double-blind, placebo-controlled clinical trial of a treatment for a well-known cognitive disorder.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clarifying Ownership of IRT Data in Clinical Trials: Distinguishing Investigator-Controlled Data from Sponsor Operational Data
2
Building More Representative Cancer Trial Populations
3
ACT Brief: Reframing Site Initiation Readiness, Operational Execution as Competitive Advantage, and a Historic Motion Sickness Approval
4
Fresh Starts, Real Readiness: Turning Site Initiation into a Trial Success Multiplier
5